Dr. Michael Harris

If you are a man on a statin and your ejaculate has disappeared, weakened, or started going backwards, you have somewhere between three and five years before the same vascular failure could reach your heart in a form your statin was never designed to prevent. I am a urologist with 19 years of practice. I have spent the last decade watching this exact timeline unfold in men on Lipitor, Crestor, and Zocor while telling none of them what was actually coming. I am writing this letter to break that silence. Men on long-term statin therapy experience retrograde ejaculation, ejaculatory volume reduction, and weakening erections at rates that almost no cardiology practice tracks because urologic outcomes are not part of cardiology follow-up. Almost none of these men are told that the same statin that is "managing" their LDL is also interfering with the cellular machinery their endothelium uses to produce nitric oxide. They are told the statin is "protecting their heart." That phrase, in isolation, is one of the most expensive half-truths in modern medicine. I'm Dr. Daniel Westbrook. I'm a board-certified urologist who spent fifteen years writing eight-minute prescriptions to men on statins without telling them what was about to happen to them next. When my own urinary and vascular symptoms started at 51, I knew something I had never explained to a single statin patient. The prostate isn't the disease. The erection isn't the disease. The retrograde ejaculation isn't the disease. They are all symptoms of one underlying problem — the systemic endothelial dysfunction that long-term HMG-CoA reductase inhibition is quietly compounding alongside the arterial inflammation it was prescribed to address. Almost every standard urological treatment added to a statin protocol masks the symptom while the underlying vascular damage continues to progress. I have treated thousands of men on long-term statins in my career. I have seen what happens at year three on Lipitor. Year five. Year eight. Year eleven. And I have seen what almost no urologist documents properly because the appointments are too short and nobody is asking the right questions. The 58-year-old. On Lipitor for 11 years. LDL "managed" at 98 every visit. His cardiologist was pleased. His PSA crept past 4 in year nine. His urologist added tamsulosin. Within six months he called the office quietly asking why nothing came out anymore. He had been on five separate prescriptions for five separate symptoms — statin, ACE inhibitor, baby aspirin, tamsulosin, and an SSRI for the depression nobody connected to the cascade — and not one of his doctors had stopped to ask whether the statin that was lowering his LDL was also impairing his endothelial nitric oxide production. Two years after that he had his first cardiac event. His LDL on the day he went down was 94. His arteries had been silently inflaming the whole time. The 54-year-old. Diagnosed with elevated cholesterol at 43. On Crestor for the last decade. LDL "perfect." Started noticing retrograde ejaculation around year seven. His cardiologist told him it was a known complication of aging and added a tadalafil prescription for the ED that was already starting. Three years later he was in his cardiologist's office with chest discomfort. LDL still managed at 96. Coronary calcium score 287. His urinary symptoms had been the warning at year five. The retrograde ejaculation had been the warning at year seven. The ED had been the warning at year eight. By the time the cath showed plaque, three different organ systems had been screaming for years and his cardiology team had answered each one with a different prescription. I see these men in follow-up appointments. They do not complain. They are grateful their LDL number looks good and that I am "managing" the prostate. But I know what they lost. They had years to address the endothelial dysfunction that was progressing underneath the lipid panel. Years to restore nitric oxide signaling that the statin had been partially blunting. Years to save themselves from a cardiac event their statin could not prevent because their plaque was not driven by serum cholesterol but by chronic arterial inflammation the statin did not address. Their symptoms had been screaming the warning the entire time. The prescriptions just turned down the volume one organ at a time while the underlying endothelial damage compounded. What almost no doctor explains to a man on a statin with retrograde ejaculation is this. Statins work by blocking an enzyme called HMG-CoA reductase. That enzyme is the rate-limiting step in your liver's production of cholesterol. Block it, and your liver makes less new cholesterol. Serum LDL drops. The number on your panel improves. That same enzyme is also the rate-limiting step in the mevalonate pathway — the cellular pathway your body uses to produce coenzyme Q10, ubiquinone, and a handful of other compounds the endothelium depends on for healthy nitric oxide production. When you block HMG-CoA reductase to lower LDL, you also blunt the production of the molecular machinery the lining of your blood vessels uses to dilate, relax, and resist inflammation. This is documented in the cardiology literature. It is sometimes called the statin paradox — the same medication that moves the cholesterol number on paper also interferes with the very system the endothelium uses to maintain its own integrity. Most patients have never heard of it. Most cardiologists do not explain it because the lipid panel improvement is real and the endothelial cost is silent. But the endothelial cost shows up downstream. In the bladder neck that no longer closes during ejaculation. In the smooth muscle of the prostate that no longer responds correctly. In the penile arteries that no longer dilate the way they did. In the coronary arteries that keep inflaming despite the LDL being "fine." The retrograde ejaculation you have been quietly living with is not the warning. The fading erections are the warning. The urinary symptoms that came before them are the warning before the warning. The plaque progression in your coronary arteries that your statin is not preventing — because the plaque was never primarily about serum LDL — is the disease. A 2006 study in European Urology documented this timeline. Erectile dysfunction precedes the first cardiovascular event by an average of three to five years. In men on long-term statin therapy with documented endothelial dysfunction, the cardiovascular event arrives despite a "well-managed" lipid panel. Men with ED on long-term statin therapy carry a higher cardiovascular risk profile than men without ED at the same LDL — because ED is the more honest signal. The LDL number is what the statin moves. The endothelial function is what determines whether plaque progresses. Your prostate symptoms are not embarrassing. Your retrograde ejaculation is not just "part of aging." They are your 10-year early warning system. And the warning is louder than your cardiologist's preferred biomarker. I was not going to start the cascade I had been writing for thousands of statin patients. And I needed to find a path that actually addressed the mechanism rather than masking the symptoms. I tried what statin patients try. CoQ10 supplementation. Logical given the mevalonate pathway interference. Helped marginally. Did not move the urinary symptoms. Mediterranean diet. Exercise. Weight loss. Helped my lipid profile further. Did not restore the morning function. Standard supplements. Saw palmetto. Pumpkin seed oil. Beta-sitosterol. L-arginine. The standard list. Did not move the needle. My PSA was stable. My LDL was managed. But my nitric oxide markers stayed low. My flow rate stayed weak. My morning erections stayed inconsistent. The statin had moved the number while the endothelial function kept declining. But I kept thinking about something that made no sense in standard practice. Endothelial dysfunction can reverse even in the presence of long-term statin therapy if the underlying inflammatory and signaling deficits are addressed. Nitric oxide production can be restored. The cardiology research had been showing this for fifteen years. Almost no one in my specialty was applying it. So why was I not applying it to myself? November 14th. 10:23 PM. I was reviewing journals after a long clinic day. Couldn't sleep. The urinary symptoms were worse. The morning erections were almost completely gone. I was scrolling through research on endothelial dysfunction interventions. Not looking for anything specific. Just exhausted. I found a paper on capsaicin and TRPV1 receptor activation in vascular endothelium. Capsaicin from chili peppers activates TRPV1 receptors in the lining of every blood vessel in the body. These receptors trigger sustained nitric oxide release through a mechanism that bypasses the mevalonate pathway interference statins create. Nitric oxide causes the smooth muscle in arteries — and in the prostate, and in the corpora cavernosa, and at the bladder neck — to function correctly. The mechanism didn't just support symptom relief. It supported endothelial repair on a pathway statins do not block. Sustained capsaicin exposure had been shown in multiple studies to reverse early endothelial dysfunction, reduce arterial inflammation, and restore nitric oxide signaling in patients with chronic vascular disease. David Julius at UCSF won the Nobel Prize in 2021 specifically for the TRPV1 discovery. I sat there at 10:23 PM staring at the diagram. The statin was managing my LDL while quietly impairing my endothelial nitric oxide production via the mevalonate pathway. The tamsulosin would have forced smooth muscle relaxation without restoring nitric oxide production at all. Two medications, both addressing surface biomarkers, neither addressing the underlying endothelial dysfunction driving the cascade. Capsaicin activates TRPV1 directly. The pathway sits outside the mevalonate cascade that statins block. The body's natural nitric oxide signaling gets restored at the source. The endothelium heals instead of being chemically suppressed. The vascular dysfunction causing your urinary symptoms, your retrograde ejaculation, your fading erections, and your continuing plaque progression despite a managed LDL — actually improves. I have been a urologist for 19 years. I have studied prostate disease for my entire career. And I had never connected therapeutic capsaicin to BPH symptoms in statin patients. The shared mechanism — the underlying endothelial and signaling root that explains why men on long-term statin therapy cluster prostate symptoms, retrograde ejaculation, fading erections, and continuing plaque progression in the same individual — was never part of any urology or cardiology curriculum. At 11:11 PM I went looking for a properly formulated capsaicin supplement. What I learned during that search is something every man on a statin who tries capsaicin needs to know. Capsaicin is fat-soluble. When you swallow a powdered cayenne capsule, your stomach acid destroys most of the active compound before it reaches your bloodstream. For capsaicin to actually reach the endothelial cells where TRPV1 lives, it must be dissolved in an oleic-acid-rich oil before it enters your body. Cold-pressed avocado oil is the carrier the research uses. Absorption rates go from 10 percent to nearly 90 percent. Almost no supplement on the market does this. Most use the cheapest possible carrier oils — soybean oil, safflower oil, sunflower oil. The same family of refined seed oils documented to drive arterial inflammation. The carrier oil works against the active compound and adds to the inflammatory load the endothelium is already carrying. I found one brand that was different. Aurivita Capsaicin Power. 3mg of pharmaceutical-grade capsaicin per softgel — the dose used in the clinical research. Suspended in cold-pressed avocado oil rather than soybean or safflower. BioPerine added to slow the liver's breakdown of the compound. Hawthorn, beetroot, Korean Red Ginseng, and vitamins D3 and K2 stacked alongside for additional vascular support. I ordered a bag that night. Three softgels in the morning with breakfast. I didn't expect miracles. The mechanism was sound. I started November 15th. November 22nd. One week in. Morning erections returning. Not consistent yet. But present for the first time in over a year. November 29th. Two weeks in. Did not wake up to urinate the previous night for the first time in two years. December 13th. Four weeks in. Morning erections every day. Full stream returning during the day. My wife asked what I had changed. "Different approach," I told her. "Whatever it is, keep doing it." January 10th. Eight weeks in. Repeat bloodwork. Blood pressure down from 144 over 88 to 126 over 78. Inflammatory markers down across the panel. LDL further down, on top of the statin effect. hs-CRP back into the normal range for the first time in years. But the part that should make every man on a statin reading this letter pay attention came when I went back to my urologist colleague for a flow study and a digital exam. He looked at my flow rate. Looked at my prostate. Looked at his notes from six months ago. "Dan, what did you do? Your flow rate is back to where it was when you were 45." I explained the TRPV1 receptor activation. The continuous nitric oxide pathway. The capsaicin mechanism. The way it sat outside the mevalonate pathway the statin was partially blocking. He was quiet for a long moment. "I have hundreds of patients on long-term statins who I have also written tamsulosin and finasteride for. If what you are describing is reproducible..." "The mechanism is real. And the cardiology research has been pointing to this for over a decade. We just have not been the specialty paying attention." He started ordering it for his statin patients with retrograde ejaculation and weak flow. I am not writing this letter because I am against statins. Statins work. They lower LDL. They have helped millions of men. If your cardiologist has prescribed one, please do not stop it without that conversation. But statins do not fix your underlying endothelial dysfunction. They lower one biomarker while partially interfering with the cellular machinery your endothelium uses to produce nitric oxide. They do not lower your accumulated cardiovascular risk to zero — because plaque progression is driven by chronic arterial inflammation and endothelial dysfunction, not solely by serum LDL. They move the number while the disease continues to progress in a quieter form. And I see what happens five years later when men with "well-managed" LDL walk into a cardiologist's office with chest pain, a perfect lipid panel, and a coronary calcium score nobody was tracking. Your prostate symptoms are not failing you. Your retrograde ejaculation is not failing you. They are warning you. The same endothelial dysfunction that your statin is partially worsening through mevalonate pathway interference is causing your urinary symptoms, your retrograde ejaculation, your fading erections, and right now, the continued plaque progression that your LDL number is not telling you about. You have two choices. Mask each symptom with a separate prescription stacked on top of the statin while the endothelial damage continues. Or address the endothelial root that is causing all of them simultaneously, on a pathway your statin does not block. I think about what I almost did. I almost added tamsulosin to my statin. I almost accepted retrograde ejaculation as the cost of "managing" my LDL while my urinary symptoms got worse. I almost became the patient I had been making for fifteen years — the man in his late fifties on five medications for five symptoms with a perfect lipid panel and a coronary calcium score climbing in the background. Because once you are deep in the cascade, you are on medications for life. Once you have a cardiac event, the damage is permanent. You do not get a second warning. Your prostate symptoms and your retrograde ejaculation are your first warning. Your only warning you can still act on. Eight weeks. That is how long it took my blood pressure to drop, my urinary symptoms to ease, my morning erections to return, and my flow rate to recover to where it had been at 45 — all while staying on my statin. Eight weeks of letting my endothelium do what it was designed to do. Heal. Your retrograde ejaculation is your check engine light. Tamsulosin is electrical tape over the indicator. Your endothelium is still failing. The mevalonate-pathway interference is still happening. You just cannot see the light anymore. But I see it every day in the men with managed LDL who come back to me three years later asking why their erections have stopped working — and six years later when their cardiologist calls me to ask what I prescribed. Every single one of them says the same thing. "I wish someone had told me my retrograde ejaculation was connected to my heart." I am telling you now. Aurivita Capsaicin Power costs $54 for 60 days. Less than a dollar a day. Compare that to a lifetime of prescriptions stacked on top of your statin while the disease compounds. Compare that to the cost of a cardiac event your statin could not prevent. It comes with a 120-day money-back guarantee. Use it for three full months. Two full bags. If your stream is not stronger, if your sleep is not better, if your morning erections are not returning, if your blood pressure and inflammatory markers are not moving, send back the bags, even empty, and get a full refund. No questions asked. aurivita.co/products/cayenne-pepper-softgels — Dr. Daniel Westbrook, MDBoard-Certified Urologist, 19 yearsPracticing physician P.S. — Give it 60 to 90 days. See the difference for yourself. You have nothing to lose except $54 and 8 to 12 weeks. The upside is the version of yourself that doesn't end up in a cath lab in three years wishing someone had explained why his statin moved the LDL number while the rest of his vascular system kept failing. P.P.S. — You are not too late yet. Your statin is doing what it was designed to do for your LDL. Your endothelium is not. Please activate TRPV1 now, before the cascade your cardiologist is missing reaches the organ they finally pay attention to.